YAP1 Recombinant Rabbit Monoclonal Antibody [SU33-06]
Usd: 205 Special Discount
Specification
Catalog# ET1608-30
YAP1 Recombinant Rabbit Monoclonal Antibody [SU33-06]
-
WB
-
IF-Cell
-
IF-Tissue
-
IHC-P
-
IP
-
FC
-
Human
-
Mouse
-
Rat
-
unconjugated
Safety datasheet
Overview
Product Name
YAP1 Recombinant Rabbit Monoclonal Antibody [SU33-06]
Antibody Type
Recombinant Rabbit monoclonal Antibody
Immunogen
Synthetic peptide within Human YAP1 aa 421-470 / 504.
Species Reactivity
Human, Mouse, Rat
Validated Applications
WB, IF-Cell, IF-Tissue, IHC-P, IP, FC
Molecular Weight
Predicted band size: 54 kDa
Positive Control
PC-12 cell lysate, rat liver tissue lysate, HeLa, human colon carcinoma tissue, human breast carcinoma tissue, human kidney tissue, HCT 116 cell lysate, Mouse liver tissue lysate, Mouse kidney tissue lysate, Mouse testis tissue lysate, Mouse skin tissue lysate.
Conjugation
unconjugated
Clone Number
SU33-06
RRID
Product Features
Form
Liquid
Concentration
Storage Instructions
Shipped at 4℃. Store at +4℃ short term (1-2 weeks). Store at -20℃ long term.
Storage Buffer
1*TBS (pH7.4), 0.05% BSA, 40% Glycerol. Preservative: 0.05% Sodium Azide.
Isotype
IgG
Purification Method
Protein A affinity purified.
Application Dilution
-
WB
-
1:1,000-1:2,000
-
IF-Cell
-
1:100
-
IF-Tissue
-
1:200
-
IHC-P
-
1:200
-
FC
-
1:1,000
-
IP
-
Use at an assay dependent concentration.
Target
Function
YAP1 (yes-associated protein 1), also known as YAP or YAP65, is a protein that acts as a transcription coregulator that promotes transcription of genes involved in cellular proliferation and suppressing apoptotic genes. YAP1 is a component in the hippo signaling pathway which regulates organ size, regeneration, and tumorigenesis. YAP1 was first identified by virtue of its ability to associate with the SH3 domain of Yes and Src protein tyrosine kinases. YAP1 is a potent oncogene, which is amplified in various human cancers.
Background References
1. Ye L et al. Decreased Yes-Associated Protein-1 (YAP1) Expression in Pediatric Hearts with Ventricular Septal Defects. PLoS One 10:e0139712 (2015).
2. Whiteman EL et al. Crumbs3 is essential for proper epithelial development and viability. Mol Cell Biol 34:43-56 (2014).
Sequence Similarity
Belongs to the YAP1 family.
Tissue Specificity
Increased expression seen in some liver and prostate cancers. Isoforms lacking the transactivation domain found in striatal neurons of patients with Huntington disease (at protein level).
Post-translational Modification
Phosphorylated by LATS1 and LATS2; leading to cytoplasmic translocation and inactivation. Phosphorylated by ABL1; leading to YAP1 stabilization, enhanced interaction with TP73 and recruitment onto proapoptotic genes; in response to DNA damage. Phosphorylation at Ser-400 and Ser-403 by CK1 is triggered by previous phosphorylation at Ser-397 by LATS proteins and leads to YAP1 ubiquitination by SCF(beta-TRCP) E3 ubiquitin ligase and subsequent degradation. Phosphorylated at Thr-119, Ser-138, Thr-154, Ser-367 and Thr-412 by MAPK8/JNK1 and MAPK9/JNK2, which is required for the regulation of apoptosis by YAP1.; Ubiquitinated by SCF(beta-TRCP) E3 ubiquitin ligase.
Subcellular Location
Cytoplasm, Nucleus.
Synonyms
65 kDa Yes associated protein antibody
65 kDa Yes-associated protein antibody
COB1 antibody
YAp 1 antibody
YAP 65 antibody
YAP antibody
YAP1 antibody
YAP1_HUMAN antibody
YAP2 antibody
YAP65 antibody
Expand65 kDa Yes associated protein antibody
65 kDa Yes-associated protein antibody
COB1 antibody
YAp 1 antibody
YAP 65 antibody
YAP antibody
YAP1 antibody
YAP1_HUMAN antibody
YAP2 antibody
YAP65 antibody
yes -associated protein delta antibody
Yes associated protein 1 65kDa antibody
Yes associated protein 1 antibody
Yes associated protein 2 antibody
yes associated protein beta antibody
YKI antibody
Yorkie homolog antibody
CollapseImages
-
Western blot analysis of YAP1 on different lysates with Rabbit anti-YAP1 antibody (ET1608-30) at 1/1,000 dilution.
Lane 1: PC-12 cell lysate (10 µg/Lane)
Lane 2: Rat liver tissue lysate (20 µg/Lane)
Predicted band size: 54 kDa
Observed band size: 75 kDa
Exposure time: 1 minute;
4-20% SDS-PAGE gel.
Proteins were transferred to a PVDF membrane and blocked with 5% NFDM/TBST for 1 hour at room temperature. The primary antibody (ET1608-30) at 1/1,000 dilution was used in 5% NFDM/TBST at 4℃ overnight. Goat Anti-Rabbit IgG - HRP Secondary Antibody (HA1001) at 1/50,000 dilution was used for 1 hour at room temperature. -
Western blot analysis of YAP1 on different lysates with Rabbit anti-YAP1 antibody (ET1608-30) at 1/5,000 dilution.
Lane 1: HepG2 cell lysate
Lane 2: Hela cell lysate
Lysates/proteins at 20 µg/Lane.
Exposure time: 25 seconds; ECL: K1801
Blocking: 5% NFDM/TBST, 1 hour at room temperature
Primary antibody: ET1608-30, 1/5,000 in primary antibody dilution buffer (K1803), overnight at 4 ℃
Secondary antibody: Goat anti-Rabbit IgG-HRP (HA1001), 1/50,000 in 5% NFDM/TBST, 1 hour at room temperature
Predicted band size: 54kDa
Observed band size: 70kDa -
Immunocytochemistry analysis of HeLa cells labeling YAP1 with Rabbit anti-YAP1 antibody (ET1608-30) at 1/100 dilution.
Cells were fixed in 4% paraformaldehyde for 20 minutes at room temperature, permeabilized with 0.1% Triton X-100 in PBS for 5 minutes at room temperature, then blocked with 1% BSA in 10% negative goat serum for 1 hour at room temperature. Cells were then incubated with Rabbit anti-YAP1 antibody (ET1608-30) at 1/100 dilution in 1% BSA in PBST overnight at 4 ℃. Goat Anti-Rabbit IgG H&L (iFluor™ 488, HA1121) was used as the secondary antibody at 1/1,000 dilution. PBS instead of the primary antibody was used as the secondary antibody only control. Nuclear DNA was labelled in blue with DAPI.
Beta tubulin (HA601187, red) was stained at 1/100 dilution overnight at +4℃. Goat Anti-Mouse IgG H&L (iFluor™ 594, HA1126) was used as the secondary antibody at 1/1,000 dilution. -
Flow cytometric analysis of HeLa cells labeling YAP1.
Cells were fixed and permeabilized. Then stained with the primary antibody (ET1608-30, 1/1,000) (red) compared with Rabbit IgG Isotype Control (green). After incubation of the primary antibody at +4℃ for an hour, the cells were stained with a iFluor™ 488 conjugate-Goat anti-Rabbit IgG Secondary antibody (HA1121) at 1/1,000 dilution for 30 minutes at +4℃. Unlabelled sample was used as a control (cells without incubation with primary antibody; black). -
Immunohistochemical analysis of paraffin-embedded human colon carcinoma tissue with Rabbit anti-YAP1 antibody (ET1608-30) at 1/200 dilution.
The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH 6.0) (high pressure) for 2 minutes. The tissues were blocked in 1% BSA for 20 minutes at room temperature, washed with ddH2O and PBS, and then probed with the primary antibody (ET1608-30) at 1/200 dilution for 1 hour at room temperature. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX. -
Immunohistochemical analysis of paraffin-embedded human breast carcinoma tissue with Rabbit anti-YAP1 antibody (ET1608-30) at 1/200 dilution.
The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH 6.0) (high pressure) for 2 minutes. The tissues were blocked in 1% BSA for 20 minutes at room temperature, washed with ddH2O and PBS, and then probed with the primary antibody (ET1608-30) at 1/200 dilution for 1 hour at room temperature. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX. -
Immunohistochemical analysis of paraffin-embedded human kidney tissue with Rabbit anti-YAP1 antibody (ET1608-30) at 1/200 dilution.
The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH 6.0) (high pressure) for 2 minutes. The tissues were blocked in 1% BSA for 20 minutes at room temperature, washed with ddH2O and PBS, and then probed with the primary antibody (ET1608-30) at 1/200 dilution for 1 hour at room temperature. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX. -
☑ Knockdown (KD)
Western blot analysis of YAP1 on different lysates with Rabbit anti-YAP1 antibody (ET1608-30) at 1/1,000 dilution.
Lane 1: HCT 116-si NT cell lysate
Lane 2: HCT 116-si YAP1 cell lysate
Lysates/proteins at 10 µg/Lane.
Predicted band size: 54 kDa
Observed band size: 75 kDa
Exposure time: 20 seconds;
4-20% SDS-PAGE gel.
Proteins were transferred to a PVDF membrane and blocked with 5% NFDM/TBST for 1 hour at room temperature. The primary antibody (ET1608-30) at 1/1,000 dilution was used in 5% BSA at 4℃ overnight. Goat Anti-Rabbit IgG - HRP Secondary Antibody (HA1001) at 1/50,000 dilution was used for 1 hour at room temperature. -
Western blot analysis of YAP1 on different lysates with Rabbit anti-YAP1 antibody (ET1608-30) at 1/1,000 dilution.
Lane 1: Mouse liver tissue lysate
Lane 2: Mouse kidney tissue lysate
Lane 3: Mouse testis tissue lysate
Lane 4: Mouse skin tissue lysate
Lysates/proteins at 40 µg/Lane.
Predicted band size: 54 kDa
Observed band size: 70 kDa
Exposure time: 2 minutes; ECL: K1802;
4-20% SDS-PAGE gel.
Proteins were transferred to a PVDF membrane and blocked with 5% NFDM/TBST for 1 hour at room temperature. The primary antibody (ET1608-30) at 1/1,000 dilution was used in 5% NFDM/TBST at 4℃ overnight. Goat Anti-Rabbit IgG - HRP Secondary Antibody (HA1001) at 1/50,000 dilution was used for 1 hour at room temperature. -
Application: IF-Tissue
Species: Human
Site: colon carcinoma
Sample: Paraffin-embedded section
Antibody concentration: 1/200
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"
Citation
-
FAM188B promotes progression of hepatocellular carcinoma by regulating YAP/TAZ via interaction with USP10
Journal: Journal Of Cancer
DOI: 10.7150/jca.125659
IF: 3.2
Application: WB,IHC
Reactivity: Mouse,Human
Publish date: 2026 Mar
-
Osteoblast-derived osteomodulin restrains osteoclastogenesis via ITGB8/RRM2-mediated reduction of mitochondrial respiration and mitochondrial ATP production
Journal: Experimental & Molecular Medicine
DOI: 10.1038/s12276-026-01682-7
IF: 12.9
Application: WB
Reactivity: Mouse
Publish date: 2026 Mar
-
SPP1 Drives Colorectal Cancer Liver Metastasis and Immunotherapy Resistance by Stimulating CXCL12 Production in Cancer-Associated Fibroblasts
Journal: Cancer Research
DOI: 10.1158/0008-5472.CAN-24-4916
IF: 16.6
Application: WB
Reactivity: Human
Publish date: 2026 Jan
-
The Herbal Compound Miltirone from Salvia miltiorrhiza Targets DJ-1 to Induce Mitophagic Dysfunction and ROS-Dependent Hippo Activation in Gastric Cancer
Journal: Phytomedicine
DOI: 10.1016/j.phymed.2026.157821
IF: 8.3
Application: WB,IHC
Reactivity: Mouse,Human
Publish date: 2026 Jan
-
OTUD4 regulates pancreatic cancer progression via Hippo/YAP axis
Journal: Neoplasia
DOI: 10.1016/j.neo.2026.101285
IF: 7.7
Application: WB
Reactivity: Human
Publish date: 2026 Feb
-
Cuproptosis-Related Ferroptosis Gene Signature: A Prognostic Tool for Colon Cancer Patients
Journal: Cancer Reports
DOI: 10.1002/cnr2.70372
IF: 1.9
Application: IHC
Reactivity: Human
Publish date: 2025 Oct
-
Targeting PIK3CB/YAP1 improves the sensitivity of paclitaxel by suppressing aging in head and neck squamous tumor cells
Journal: Cancer Cell International
DOI: 10.1186/s12935-025-03818-7
IF: 5.3
Application: WB
Reactivity: Human
Publish date: 2025 May
-
The potential of TAOK1 as a new therapeutic target for the treatment of cancer cachexia-associated muscle atrophy
Journal: Pharmacological Research
DOI: 10.1016/j.phrs.2025.107763
IF: 9.1
Application: WB
Reactivity: Mouse
Publish date: 2025 May
-
Decoupling of Density-Dependent Migration/Proliferation Dichotomy on Surface Potential Gradient
Journal: ACS Applied Materials & Interfaces
DOI: 10.1021/acsami.4c18787
IF: 8.3
Application: WB
Reactivity: Human
Publish date: 2025 Mar
-
TET2 orchestrates YAP signaling to potentiate targetable vulnerability in hepatocellular carcinoma
Journal: Cell Death & Disease
DOI: 10.1038/s41419-025-07745-3
IF: 9.6
Application: WB,IHC
Reactivity: Mouse,Human
Publish date: 2025 Jun
-
ARRDC3 promotes lysosome-mediated YAP degradation to inhibit enterovirus replication
Journal: Virologica Sinica
DOI: 10.1016/j.virs.2025.07.009
IF: 4
Application: WB
Reactivity: Human
Publish date: 2025 Jul
-
Dimethyl fumarate promotes the degradation of HNF1B and suppresses the progression of clear cell renal cell carcinoma
Journal: Cell Death & Disease
DOI: 10.1038/s41419-025-07412-7
IF: 8.1
Application: WB,Co-IP
Reactivity: Human
Publish date: 2025 Feb
-
Exploring YAP1-related TIME in SCLC: implications for survival and treatment response to immuno-chemotherapy
Journal: Cancer Drug Resistance
DOI: 10.20517/cdr.2024.177
IF: 4.6
Application: mIHC
Reactivity: Human
Publish date: 2025 Feb
-
Identification of ANXA1 as a Novel Upstream Negative Regulator of Notch1 Function in AML
Journal: Advanced Science
DOI:
IF: 14.3
Application: WB
Reactivity: Human
Publish date: 2024 Oct
-
Gq/G11 oncogenic mutations promote PD-L1 expression and suppress tumor immunity
Journal: European Journal Of Cell Biology
DOI:
IF: 4.5
Application: WB
Reactivity: Human
Publish date: 2024 Nov
-
PD-1/PD-L1 Interaction Upregulates YAP1 Expression in HepG2 Cells Through MAPK/ERK Pathway
Journal: Natural Product Communications
DOI:
IF: 1.8
Application: WB
Reactivity: Human
Publish date: 2023 Oct
-
GALNT12 promotes fibrosarcoma growth by accelerating YAP1 nuclear localization
Journal: Oncology Letters
DOI: 10.3892/ol.2023.14131
IF: 2.9
Application: WB
Reactivity: Human
Publish date: 2023 Nov
-
Yes-associated protein promotes endothelial-to-mesenchymal transition of endothelial cells in choroidal neovascularization fibrosis
Journal: International Journal Of Ophthalmology
DOI:
IF: 1.779
Application: WB
Reactivity: Human
Publish date: 2022 May
-
Intermittent Hydrostatic Pressure Promotes Cartilage Repair in an Inflammatory Environment through Hippo-YAP Signaling In Vitro and In Vivo
Journal: Biomed Research International
DOI:
IF: 3.246
Application: WB,IHC-P
Reactivity: Rat
Publish date: 2022 Aug
-
Aqueous extract of Taxus chinensis var. mairei regulates the Hippo-YAP pathway and promotes apoptosis of non-small cell lung cancer via ATF3 in vivo and in vitro. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 138, 111506.
Journal: Biomedicine & Pharmacotherapy
DOI:
IF: 4.545
Application: WB
Reactivity: Mouse,Human
Publish date: 2021 Jun